Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-05-25Clinical Trial Update: Pantoprazole Prophylaxis Against Delayed CINV for Patients Receiving Breast Cancer Chemotherapy [Phase 2]
A Phase 2 trial evaluating pantoprazole as a prophylaxis against delayed chemotherapy-induced nausea and vomiting in patients receiving brea…
-
CLINICAL_TRIALS trial_result · 2022-05-25Clinical Trial Update: BreCLIM-2 - A RCT Investigating Local Treatment for Breast Cancer Liver Metastases [Phase 3]
Phase 3 trial update for BreCLIM-2 evaluating local treatment for breast cancer with liver metastases; currently recruiting.
-
FDA approval · 2022-05-24FDA Approved: EXEMESTANE — Supplemental Application (Florida Pharmaceutical Products, LLC)
FDA approved a supplemental application for exemestane submitted by Florida Pharmaceutical Products, LLC.
-
CLINICAL_TRIALS trial_result · 2022-05-23Clinical Trial Update: Diet, Exercise and Vitamin D in Breast Cancer Recurrence [Phase 3]
A Phase 3 clinical trial evaluating the impact of diet, exercise, and vitamin D on breast cancer recurrence.
-
FDA approval · 2022-05-20FDA Approved: EXEMESTANE — Original Application (Aurobindo Pharma Limited)
The FDA approved the original ANDA for Exemestane from Aurobindo Pharma Limited, establishing a generic aromatase inhibitor. It relates to t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-05-19Clinical Trial Update: Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer [Phase 2]
Phase 2 study of trastuzumab with etoposide in HER-2 positive metastatic breast cancer was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-19Clinical Trial Update: MBSR During AI Therapy for Breast Cancer [NA]
A completed clinical trial evaluating mindfulness-based stress reduction (MBSR) during AI therapy for breast cancer, with results posted in …
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: Ribociclib and Aromatase Inhibitor in Treating Older Participants With Hormone Receptor Positive Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating ribociclib in combination with an aromatase inhibitor for older adults with estrogen receptor-positive, HE…
-
CLINICAL_TRIALS trial_result · 2022-05-13Clinical Trial Update: Study of Euthyroid Hypothyroxinemia in Metastatic Breast Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating euthyroid hypothyroxinemia in metastatic breast cancer was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-13Clinical Trial Update: Brain Stimulation For Cancer Smokers [NA]
Clinical trial on brain stimulation for cancer patients has completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-11Clinical Trial Update: A Randomized Phase II Study Of Eribulin Mesylate With or Without Pembrolizumab For Metastatic Hormone Receptor Positive Breast Cancer [Phase 2]
Phase II randomized trial evaluating eribulin mesylate with or without pembrolizumab in metastatic hormone receptor-positive breast cancer c…
-
CLINICAL_TRIALS trial_result · 2022-05-11Clinical Trial Update: Acupuncture in Reducing Chemotherapy-Induced Peripheral Neuropathy in Participants With Stage I-III Breast Cancer [NA]
Clinical trial results for acupuncture to reduce chemotherapy-induced peripheral neuropathy in early-stage breast cancer patients have been …
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate [Phase 3]
Phase 3 trial update providing long-term safety follow-up and examining long-term exposure to abiraterone acetate in metastatic castration-r…
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: Phase IB & II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR+, HER2+ Advanced Breast Cancer Patients [Phase 1, Phase 2]
Phase IB/II study evaluating ribociclib in combination with trastuzumab and letrozole in postmenopausal HR+, HER2-positive advanced breast c…
-
CLINICAL_TRIALS trial_result · 2022-05-09Clinical Trial Update: Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC [Phase 3]
Phase 3 trial evaluating ribociclib with letrozole for HR+ HER2- advanced breast cancer in men and pre/postmenopausal women has completed wi…
-
CLINICAL_TRIALS trial_result · 2022-05-06Clinical Trial Update: Avoiding Growth Factor During Paclitaxel Treatment in Breast Cancer [Phase 2]
Phase 2 trial evaluating avoidance of growth factor support during paclitaxel treatment in early stage breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-05-06Clinical Trial Update: An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide [Phase 2]
Phase 2 open-label study evaluating the incidence and severity of diarrhea in early-stage HER2-positive breast cancer patients treated with …
-
FDA approval · 2022-05-04FDA Approved: PIQRAY — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for PIQRAY (alpelisib) submitted by Novartis Pharmaceuticals Corporation.
-
FDA approval · 2022-05-04FDA Approved: KISQALI FEMARA CO-PACK — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application to authorize Kisqali Femara Co-Pack, a co-packaged product combining ribociclib and letrozole for th…
-
CLINICAL_TRIALS trial_result · 2022-05-02Clinical Trial Update: Randomized Controlled Trial of Neo-adjuvant Progesterone and Vitamin D3 in Women With Large Operable Breast Cancer and Locally Advanced Breast Cancer [Phase 3]
A Phase 3 randomized trial evaluating adjuvant progesterone and vitamin D3 in women with locally advanced or large operable breast cancer; t…
-
CLINICAL_TRIALS trial_result · 2022-04-29Clinical Trial Update: DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03] [Phase 3]
Phase 3 DESTINY-Breast03 compared trastuzumab deruxtecan (DS-8201a) with ado-trastuzumab emtansine (T-DM1) in HER2-positive unresectable/met…
-
CLINICAL_TRIALS trial_result · 2022-04-28Clinical Trial Update: Neoadjuvant Therapy in Clinical Stage I-III HER2-positive Breast Cancer. [Phase 2]
Phase 2 neoadjuvant therapy study for clinically staged I-III HER2-positive breast cancer; results completed and posted.
-
CLINICAL_TRIALS trial_result · 2022-04-28Clinical Trial Update: Efficacy and Safety of Sintilimab and Apatinib Combined Chemotherapy in Breast Cancer [Phase 2]
Phase 2 trial evaluating the efficacy and safety of the combination of sintilimab and apatinib with chemotherapy in breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: Evaluation of Tamoxifen's Efficacy for ER/PR Negative,ER-beta Positive Operable Breast Cancer Patients [Phase 3]
Phase 3 trial evaluating tamoxifen efficacy in ER/PR-negative, ER-beta positive operable breast cancer patients is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2022-04-26Clinical Trial Update: PLD-cyclophosphamide-Nab-P Continuously Combined With Dual HER2 Blockage for HER2-positive Breast Cancer [Phase 2]
Phase 2 trial update exploring continuous combination of pegylated liposomal doxorubicin (PLD) with cyclophosphamide and Nab-Paclitaxel in H…